映射抑郁与焦虑症状及行为维度的神经环路生物型
研究开发并测试了量化6个脑环路的系统,在抑郁和焦虑样本(N=250)中证明任务态无显著激活的突显网络和默认模式网络整体连接下降映射到跨诊断的核心症状和日常功能差。环路功能障碍评分还能区分抗抑郁药和行为干预的治疗反应(独立样本n=205)。
要点
- 任务态无显著激活的突显网络和默认模式网络连接下降对应焦虑回避、快感缺失等跨诊断症状。
- 任务诱发认知控制和情感环路的区域功能障碍可能涉及认知和效价一致的情绪功能症状。
- 环路功能障碍评分可区分抗抑郁药与行为干预的治疗反应。
核心结论
- 研究识别出与心境和焦虑障碍跨诊断症状相关的环路维度,为标准化环路评估和更精准分类及治疗靶点提供基础。
研究设计与样本
- 开发并测试量化6个脑环路的新系统,在个体患者水平可重复实现,并相对于健康参考样本标准化环路定义。
- 在抑郁和焦虑的主要样本与泛化样本(N=250)中验证,并在独立样本(n=205)中检验治疗反应区分。
主要发现
- 任务态无显著激活的突显网络和默认模式网络整体连接下降映射到焦虑回避、快感缺失、威胁失调和负性情绪偏向及更差日常功能。
- 任务诱发认知控制和情感环路的区域功能障碍可能涉及认知和效价一致的情绪功能症状。
- 环路功能障碍评分在独立样本中区分抗抑郁药和行为干预的治疗反应。
临床怎么用
- 标准化环路评估可用于研究和临床,以推进跨诊断分类和精准治疗靶点选择。
- 环路功能障碍评分可能辅助区分抗抑郁药与行为干预的治疗反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite tremendous advances in characterizing human neural circuits that govern emotional and cognitive functions impaired in depression and anxiety, we lack a circuit-based taxonomy for depression and anxiety that captures transdiagnostic heterogeneity and informs clinical decision making. METHODS: We developed and tested a novel system for quantifying 6 brain circuits reproducibly and at the individual patient level. We implemented standardized circuit definitions relative to a healthy reference sample and algorithms to generate circuit clinical scores for the overall circuit and its constituent regions. RESULTS: In new data from primary and generalizability samples of depression and anxiety (N = 250), we demonstrated that overall disconnections within task-free salience and default mode circuits map onto symptoms of anxious avoidance, loss of pleasure, threat dysregulation, and negative emotional biases-core characteristics that transcend diagnoses-and poorer daily function. Regional dysfunctions within task-evoked cognitive control and affective circuits may implicate symptoms of cognitive and valence-congruent emotional functions. Circuit dysfunction scores also distinguished response to antidepressant and behavioral intervention treatments in an independent sample (n = 205). CONCLUSIONS: Our findings articulate circuit dimensions that relate to transdiagnostic symptoms across mood and anxiety disorders. Our novel system offers a foundation for deploying standardized circuit assessments across research groups, trials, and clinics to advance more precise classifications and treatment targets for psychiatry.
引用
- Goldstein-Piekarski AN, Ball TM, Samara Z, et al. Mapping Neural Circuit Biotypes to Symptoms and Behavioral Dimensions of Depression and Anxiety. Biol Psychiatry. 2021. PMID: 34482948. doi:10.1016/j.biopsych.2021.06.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。